Medifast | 4: Statement of changes in beneficial ownership of securities-Officer Maloney James P.
Medifast | 4: Statement of changes in beneficial ownership of securities-Officer MacKenzie Jonathan Barrett
Medifast | 4: Statement of changes in beneficial ownership of securities-Officer Chard Daniel R
Medifast | 4: Statement of changes in beneficial ownership of securities-Officer MacKenzie Jonathan Barrett
Medifast | 4: Statement of changes in beneficial ownership of securities-Officer Chard Daniel R
Medifast | 4: Statement of changes in beneficial ownership of securities-Officer Maloney James P.
Medifast | 4: Statement of changes in beneficial ownership of securities-Director SCHLACKMAN SCOTT
Medifast | 144: Notice of proposed sale of securities pursuant to Rule 144
Medifast | 8-K: Medifast Announces Fourth Quarter and Full Year 2023 Financial Results
Medifast | 10-K: Annual report
Medifast | 4: Statement of changes in beneficial ownership of securities-Officer Chard Daniel R
Medifast | 4: Statement of changes in beneficial ownership of securities-Officer Maloney James P.
Medifast | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(15.49%)
Medifast | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Renaissance Technologies LLC 26-0385758(6.96 %),RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734(6.96 %)
Medifast | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(16.6%)
Medifast | 8-K: Current report
Medifast | 4: Statement of changes in beneficial ownership of securities-Director Thomas Andrea B
Medifast | 4: Statement of changes in beneficial ownership of securities-Director Hoer Michael A.
Medifast | 4: Statement of changes in beneficial ownership of securities-Director SCHLACKMAN SCOTT
Medifast | 4: Statement of changes in beneficial ownership of securities-Director BROWN JEFFREY J
No Data